Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2448.0000 8.40 (0.34%)
NSE Oct 03, 2025 15:31 PM
Volume: 606.9K
 

2448.00
0.34%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors increased from 640 to 648 in Jun 2025 qtr.
More from Mankind Pharma Ltd.
Recommended